GLP-1 Weight Loss Medications: Expert Perspectives on Efficacy, Candidates, and Long-Term Weight Maintenance
核心洞察
Dr. Christopher Jones of Memorial Health System reports Semaglutide yields 10–12% weight loss, Tirzepatide 15–20%, and the investigational Retatrutide 20–25% after more than a year of use.
Gallup data shows GLP-1 usage nearly tripled from 6% in 2024 to 15% in 2026, underscoring sharply rising adoption.
Registered dietitian Sarah Smith warns that weight often returns after stopping GLP-1s and emphasizes the need for consistent eating and exercise habits alongside pharmacotherapy.
As public interest in GLP-1 receptor agonists for weight loss continues to surge, clinicians are offering clearer guidance on who stands to benefit, what results patients can expect, and the critical lifestyle factors that determine long-term success.
Dr. Christopher Jones of Memorial Health System in Gulfport, Mississippi, outlined the current landscape of GLP-1 medications, noting that ideal candidates are primarily patients with diabetes (搜索) or a body mass index (BMI) over 30. "We talk options. We talk costs, side effects, method of administration," Jones said. "Some of these are injectable, some of them are oral, and then we try to pick the best medication for the patient and use kind of a patient-centered approach."
Efficacy Across the GLP-1 Class
Jones detailed the weight loss outcomes associated with the major agents currently available or in development. "Semaglutide typically has about a 10 to 12% weight loss after better than a year on it. Tirzepatide, upwards of 15 to 20%, and Retatrutide, which is a new one and it's not on the market yet, 20 to 25%," he said. "All of them, after about a year, show promising weight loss."
Retatrutide, a triple-hormone receptor agonist, is currently in phase three clinical trials and has not yet received market authorization. The commonly known medications on the market include Semaglutide, Ozempic, and Tirzepatide, all of which carry both diabetic and weight loss indications.
Regarding administration, Jones explained that injectable formulations are typically dosed once weekly, while oral forms require daily dosing.
Side Effect Profile
The most common side effects across GLP-1 medications are gastrointestinal in nature. "Acid reflux, upset stomach, maybe some nausea. Those are the common ones. The more severe ones are throwing up or diarrhea," Jones said. Sarah Smith, a registered dietitian with University of Michigan Health Sparrow (搜索), similarly noted that because GLP-1 medications slow the digestive system, nausea and vomiting are frequently reported.
The Challenge of Weight Maintenance After Discontinuation
While GLP-1 medications can produce substantial weight loss, health experts are cautioning about the challenges that emerge when patients stop taking them. A Gallup poll released in July found that in 2024, 6% of people surveyed had used a GLP-1 drug; two years later, that figure nearly tripled to 15%.
Smith emphasized that patients initiating GLP-1 therapy should concurrently work with a dietitian. "Because registered dietitians can help teach you and help guide you on building healthy habits for balanced meals and consistent eating patterns and help you build an exercise routine," she said.
Smith warned that staying on the medication is not a long-term option for everyone, and when patients discontinue treatment, the weight they lost often returns. "Are you going to be able to eat this way five years from now, 10 years from now...We need to make sure we're practicing consistency — consistent eating patterns and consistent exercise patterns," she said.
Alex Thompson, clinical nutrition manager at University of Michigan Health-Sparrow, reinforced that weight management deserves serious clinical attention. "Weight management is an important aspect of all of our health. Although other conditions such as diabetes (搜索), hypertension or kidney disease might be concerns for some people, obesity (搜索) and weight management are certainly just as valid health concerns," Thompson said.
Patient-Centered Decision Making
Jones advised that patients interested in GLP-1 medications should contact a provider versed in GLP-1s to discuss options, costs, side effects, and method of administration. Experts across both institutions agreed that all patients should talk with their doctor about their specific needs before embarking on treatment.